News
Mark Cuban Cost Plus Drug Co. has secured another partnership targeting the specialty pharmaceutical market, according to an April 28 news release shared with Becker’s. EverPharm, a specialty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback